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Abkürzungsverzeichnis 
 
 
 
ALARA    as low as reasonably achievable 
DMSA    dimercaptosuccinic acid 
EAU     european association of urology 
ESPU     european society of pediatric urology 
ESRD     end stage renal disease 
fUTI     febrile urinary tract infection 
i.v.      intravenous 
NICE     national institute for health and care excellence  
PIC     positioning instillation of contrast 
UPJO     ureteropelvic junction obstruction 
VCUG    voiding cystourethrography 
VUR     vesicoureteric reflux 
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Einleitung / Introduction 
 
Febrile urinary tract infections in children – epidemiology and significance 
 
Febrile urinary tract infections (fUTI) are common in childhood. 3-5% of girls as well 
as 1-2% of boys are concerned at least once during childhood[1]. During the first two 
years of life, 5-8% of all febrile episodes are caused by a UTI, they account for 0.7% 
of all office visits and 5-14% of all visits to an emergency room annually[2]. In the first 
year of life, boys and girls show the same incidence, thereafter, girls are far more 
often concerned. Uncircumcised boys have a relative risk of up to 8 during the first 
two years of life as compared to boys who underwent newborn circumcision[3]. With 
a prevalence varying from 1.8-7.5%, fUTIs are the most common bacterial infection 
in childhood and account for an important morbidity.   
 
Children with fUTIs often present with rapid onset, high fever (>38.5°C), serious 
illness, requiring i.v. hydration and often also i.v. antibiotics while septic shock occurs 
mostly when obstruction (e.g. Megaureter, Urolithiasis) is present[4]. The most 
severe clinical course must be expected in young infants, who are also the group of 
patients at the highest risk for subsequent renal damage and bacteremia[5]. 
Typically, children with fUTIs present in a markedly reduced condition with fever, 
lethargy, reduced oral intake and greyish skin color. Specific symptoms, as for 
example flank pain, micturition frequency as well as alguria are uncommon in infants 
or toddlers and only occur in toilet trained pre-school aged children on a regular 
basis. The younger a child is, the less specific symptoms might be: in some cases of 
UTI during the first 2-3 month of life even hypothermia, excitability or failure to thrive 
over a longer period of time might be the only symptoms, rendering a urinalysis 
including culture an integral part of primary diagnostics[4].  
In general, UTIs are classified according to site, to the presence of complicating 
factors as well as to symptoms. Whereas UTIs concerning the lower urinary tract are 
a rare event to be detected in very young children and rarely present with the typical 
symptoms of urge, alguria or incontinence before school-age, fUTIs are most 
commonly involving the kidneys[6]. The term pyelonephritis is often used to describe 
the involvement of the kidneys. Bacterial invasion is causing an interstitial nephritis 
with an important involvement of the urothelium of the whole urinary tract – 
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dependent on the causative bacterial uropathogen with more or less destruction of its 
integrity. Whereas uncomplicated UTIs are defined to occur in patients with 
morphologic and functional normal upper and lower urinary tract, normal renal 
function and a competent immune system, any UTI in patients with mechanical (e.g. 
UPJO), anatomical (e.g. calyceal diverticula) or functional (e.g. vesicoureteric reflux) 
abnormalities of the urinary tract is considered a complicated UTI. Lastly, there are 
asymptomatic UTIs, also in children, defined as the presence of uropathogenic 
bacteria without any host response leading to symptoms, however, excluding the 
presence of leucocyturia.  
The rates of resistant bacteria are on the rise, also in pediatric urinary tract infections. 
While this is still a limited concern in central Europe  there have been recent reports 
on a fast rising prevalence of multidrug resistant uropathogenic bacteria, mostly from 
treshold countries[7,8].  
The most common pathogens causing fUTI in children are Escherichia Coli. Other 
common uropathogenic bacteria as for example Klebsiella Pneumoniae, 
Enterococcus spp and Pseudomonas are more frequent in childhood as compared to 
later in life, more importantly, there is a higher risk of sepsis in the pediatric 
community as compared to adults[9].  
 
Of all children presenting with their first fUTI, an important proportion, varying 
between 30 and 50% in different reports, is prone to recurrent episodes[10]. While in 
older, school-aged children, where especially girls are prone to recur at a probability 
as high as 80% linked to bladder and bowel emptying problems, in toddlers, infants 
and babies the most likely underlying cause are congenital malformations of the 
urinary system[8]. The main concern in these children is the presence of VUR or 
other functional or anatomical abnormalities involving a higher risk for subsequent 
UTI episodes as well as kidney damage.  
On how to define kidney damage linked to fUTI there is some controversy. During the 
last decades imaging of tubular uptake of DMSA emerged as the gold standard 
method to detect renal involvement in acute fUTI as well as residual “scarring” that 
equals permanent kidney damage. In a series of seminal papers, Coulthard and 
colleagues proved, that neither – as thought before – do kidneys outgrow the risk of 
acquiring damage during fUTIs, nor is most of the damage happening before 
birth[11,12]. The pathophysiological backbone of acquired kidney function loss during 
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fUTIs was investigated as early as in the 1970ies by Risdon and Ransley, proving 
that anatomical variations of renal papillae determine the risk of parenchymal 
involvement and eventual parenchymal damage during UTIs[13]. 
Prompt treatment can prevent ultimate scar formation and protect children from 
kidney function loss[14]. 
In the largest metaanalysis presently availably including a total of 6457 patients, the 
prevalence of VUR in children after their first fUTI is reported as 32%[15]. According 
to some smaller series, after the second fUTI, the risk rises to 55%[16].  
While this equals our experiences[17], there is a proportion of children where the 
anatomic phenomenon of VUR cannot be diagnosed by a conventional VCUG who 
are still at risk. In these cases, a so-called “occult VUR” might be present, that is 
defined by a novel diagnostic approach involving a directed jet of contrast medium, 
directed at the ureteral orifice via cystoscopy under general anesthesia – PIC 
cystography[18]. Whilst initially debated, in the meanwhile multiple studies proved the 
value of this diagnostic technique in the routine management of children presenting 
with fUTIs[19,20]. 
Kidney damage caused by VUR is termed reflux nephropathy, ultimately leading to 
ESRD. According to national and international transplant registers VUR accounts for 
up to 6.5% of all pediatric kidney transplantations and for up to 3.5% of patients with 
chronic renal failure in the US and 7–17% worldwide[21]. Of all children, who are 
treated within modern health care systems with access to antibiotics and eventually 
surgical interventions for persistent VUR associated with repeated fUTIs, only very 
few develop progressive renal failure culminating in ESRD.  
 
Primary Diagnostics in febrile urinary tract infections 
 
As eluded on above, symptoms – as the only symptom in most cases is high fever – 
are unlikely to be of high value in the diagnosis of fUTIs, especially in infants. Also, 
as proven by an experimental evaluation of 110 urine samples, urine smell is unlikely 
to direct suspicion correctly at the presence of a UTI[22]. Imaging – especially acute 
phase  DMSA scanning or – as recently published – diffusion weighted MRI shows a 
high sensitivity[6]. These imaging test, however, are not only involving radiation 
(DMSA) and are cost intensive but also are usually not available in primary care 
settings. Ultrasound, while being available is not specific enough for routine primary 
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diagnostic use. Laboratory tests also are mostly not specific enough, considering 
PCT, however, a close relationship with renal involvement has been proven for PCT 
values over 0.5ng/ml in proven fUTIs[23].   
Diagnosis – in primary care settings – therefore mainly relies on urine sampling as 
well as directed out-ruling of alternative underlying causes for the presenting illness. 
Although it is well known that fUTIs not only are highly prevalent but also linked to a 
considerably morbidity, they are under-diagnosed. Of all serious bacterial infections, 
fUTI is the one most commonly missed, what is attributed to the low sensitivity of 
diagnostic tools availably to most primary care physicians as well as the relatively 
high invasiveness of sterile urine sampling by puncture of catheterism as well as the 
low availability of high quality microbiological analysis[24]. In view of the fact that the 
extent of definitive kidney function loss is closely linked to the interval between 
symptom (fever) onset and the start of a adequate therapy this seems even more 
relevant[14,25,26]. Set aside renal function loss, there are data from prospective 
cohort studies proving that the sooner an adequate treatment is established the 
sooner the child will recover[27]. 
Bag-urine, that is used with high prevalence in infants in primary care settings has 
been shown to be of a despicable specificity[28], being prone to contamination rates 
as high as 46%[29]. Its use in daily routine is therefore limited to excluding a UTI – if 
dipstick results are negative a positive culture result (of sterile acquired urine) is 
highly unlikely. There, is however, as mentioned above a subgroup of mainly very 
young infants in their first 2 months of life with clinically relevant UTIs but no 
Leucocyturia that should undergo sterile urine sampling at any clinical suspicion of a 
UTI[5].  
 
In our first paper we aimed at assessing the common practice concerning urine 
testing. Our hypothesis was that if bag-urine testing would be less accurate in UTI 
diagnosis, those patients would have a lower rate of underlying congenital 
malformations of the urinary tract – mainly VUR. We did, however, find that in 
conjunction with a well-performed clinical exam at time of the presumed fUTI a 
positive bag-urine culture is (post-hoc!) dependable evidence for a relevant UTI that 
should be followed-up as meticulously as a fUTI proven by sterile urine sampling[17].  
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Secondary Diagnostics after febrile urinary tract infections 
 
After a first UTI, the risk for further UTIs amounts to 30-70%. It is dependent mainly 
on the presence of congenital malformations – predominantly VUR – in infants and 
bladder-bowel emptying problems in older children. Therefore, secondary diagnostics 
are warranted in most children after their first febrile UTIs, as to the current 
EAU/ESPU Guidelines, after an orienting sonography exam, all infants except boys 
experiencing their first fUTI after the age of 12 months with unsuspicious sonography 
findings should have further diagnostics. 
Fluoroscopic voiding cystourethrography (VCUG) remains the gold standard for the 
diagnosis of VUR in children, whereas dimercaptosuccinic acid (DMSA) scan is the 
standard investigation detecting renal involvement or, eventually, renal scarring after 
fUTIs[4]. 
 
The “bottom up approach” starts with an initial VCUG to determine the presence of 
VUR, followed by a DMSA scan in children with VUR to determine kidney 
involvement. Up to 70% of all primary VCUGs may lead to negative results, 
translating to many children undergoing unnecessary discomfort and radiation 
burden and into a risk of missed upper tract affections resulting in wrong 
assumptions on the need for further treatment.  
Alternatively, performing a DMSA scan first (“top-down approach”) can be a valid 
option in order to optimize further management as well as to spare children 
unnecessary invasive diagnostic studies. With this approach, however, many VURs 
are not diagnosed: in our data (not published) 50% of all VURs would be missed. In 
an evaluation of the NICE guidelines a diagnostic approach based on primary DMSA 
scans showed a considerable probability of diagnosing VUR as such with a 
comparative sensitivity of only 10%[12]. 
There is, however, a recent report comparing guideline recommendations as to 
secondary diagnostics UTIs in children, stating a very low level of consent[30]. The 
underlying problem lies in the fact, that all diagnostics involve burden as well as cost 
for child and health care system, the rate of 32% of diagnosed VUR seems rather 
low. Consequently, there have been various attempts to render the imaging pathway 
more effective as compared to “top-down” and “bottom-up” as described above by 
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including more factors into the decision making algorithm in order to tailor individual 
diagnostics and limit the diagnosis of VUR to those, who would profit most[31].  
 
 
Radiation burden in pediatric imaging – significance and sequelae 
 
Besides the difficult indication that where all possible benefits of a timely diagnosis of 
VUR have to weighed against the invasive nature of the exams (catheterism, needle 
puncture with associated pain) there is another important factor: the involved dose of 
ionizing radiation.  
 
The knowledge on the dose-effect relationship of exposure to ionizing radiation is 
drawn from experiences after the observation of survivors after the atom bomb 
detonations in Japan. These data have been extrapolated to lower levels of radiation, 
resulting in an excess risk of cancer development of 5% per Sv [32,33]. The critical 
indicator of risk is the relative organ effective dose, which is higher in children 
because despite lower energy applied, the organs are smaller evenmoreso [34-36]. 
As a result with an added effect of a longer lifespan on the long-term detrimental 
effects on DNA, a one-year old child exposed to a certain amount of ionizing 
radiation, is 10-15 times more likely to eventually show sequelae as compared to an 
adult [37]. Whereas radiation doses conveyed in isolated exams are – even for CT – 
usually relatively low, the cumulative dose of repeated investigations and the fact that 
exposure occurs in early childhood has to be taken most seriously. fUTIs are a 
frequent cause for indication of exams involving ionizing radiation in early childhood – 
namely VCUGs as well as DMSA scans. The responsibility for possible late sequelae 
starts with a tailored indication and continues in capitalizing any means to limit 
radiation dose involved in each single examination. 
 
This is what my second study aimed at investigating: While there are VCUG 
techniques deemed to involve relatively lower radiation doses as compared to a 
conventional, fluoroscopic VCUG, dose is also dependent of the individual 
examination technique. During the last 20 years, digital ultra short-pulsed fluoroscopy 
with last image hold evolved to deliver excellent image quality. By tailored exposures 
in order to reduce fluoroscopy time and use of blinds as well as laser targeting, which 
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as a sole measure already has been shown to reduce exposure time by 25%[38]. We 
could show in our study, that with using all means to reduce radiation burden the 
involved dose is as low as a mean of 0.018mSv equalling 5-7 hours of flight or 2.3 
days of usual surrounding (earth and cosmic) radiation and much lower than the 
dose of an isotope cystography, that was previously deemed the most radiation 
sparing approach to VUR diagnostics. However, in most reports in the literature, 
doses up to 100 times higher are described[39]. Therefore, the combination of a wise 
indication for either exam with a timely and radiation sparing examination technique 
in line with the ALARA principle should be standard in imaging after pediatric urinary 
tract infections. 
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Zusammenfassung 
Der fieberhafte Harnwegsinfekt ist eine häufige Problemstellung  in der 
kinderurologischen Praxis und verantwortlich für beträchtliche Morbidität, im weiteren 
Verlauf möglicherweise auch für Nierenfunktionsverlust mit der – seltenen – 
Konsequenz einer chronischen Niereninsuffizienz. Die klinischen Symptome sind oft 
unspezifisch, insbesondere bei kleinen Kindern, die gleichzeitig das höchste Risiko 
für komplizierte Verläufe aufweisen. In Hinblick auf die hohe Rate an Rezidivinfekten, 
meist auf Basis von zugrundeliegenden Fehlbildungen des Harntraktes und Blasen- 
sowie Darmentleerungsstörungen, ist eine akkurate primäre und sekundäre 
Diagnostik entscheidend.  
Von allen bakteriellen fieberhaften Erkrankungen bei kleinen Kindern, sind 
Harnwegsinfekte die am häufigsten primäre „übersehene“ Diagnose. Die Ursache 
dafür liegt darin, dass die Diagnose des Harnwegsinfektes bei unspezifischer Klinik 
auf einer genauen Harndiagnostik beruht. Diese erfordert eine sterile Urinprobe – 
gewonnen entweder per suprapubischer Punktion oder transurethralem 
Katheterismus. In der täglichen Praxis werden jedoch meist Harnbeutel verwendet, 
die laut der verfügbaren Literatur bezüglich der Diagnose eines Harnwegsinfektes 
sehr unspezifisch sind. Wir konnten jedoch zeigen, dass ihre Verwendung bei der 
Diagnose eines fieberhaften Harnwegsinfektes kein unabhängiger negativ prädiktiver 
Faktor für das Vorhandensein eines vesikoureteralen Refluxes darstellt und auch 
solche Diagnosen letztlich ernst genommen werden müssen.   
Bezüglich des Zeitpunktes und der Indikation zur sekundären Diagnostik nach 
fieberhaften Harnwegsinfekten existiert kein Konsensus. Eine 
Miktionszysturethrographie oder ein Dimercaptosuccinylsäure Scan sind in den 
meisten Fällen indiziert – beides bringt eine Exposition gegenüber ionisierender 
Strahlung mit sich. Aufgrund des besonders hohen Risiko für sekundäre Malignome 
bei Kindern muss dies sehr kritisch gesehen werden. Wir haben das Potential zur 
Dosisreduktion bei der konventionellen Durchleuchtungs-Miktionszysturethrographie 
im Vergleich zur direkten Isotopencystographie untersucht und konnten zeigen, dass 
mittels moderner Techniken eine weitere signifikante Verbesserung möglich ist.  
Zusammenfassend  zeigen unsere Ergebnisse wesentliche Implikationen rationaler 
primärer Diagnostik auf und unterstreichen die Wichtigkeit des Ausschöpfens aller 
Möglichkeiten zur Minimierung der Strahlendosis in der Abklärung nach fieberhaften 
Harnwegsinfekten bei Kindern.  
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Summary 
Febrile urinary tract infections are commonly encountered in pediatric urologic 
practice and account for a high burden of morbidity, eventually also for renal function 
loss with the rare but severe consequence of end stage renal disease. Their clinical 
symptoms are often unspecific, especially in babies and infants, who are at the same 
time at the highest risk of complicated clinical courses involving bacteremia or sepsis 
as well as renal function loss by scarring. In regard to high recurrence rates, often 
caused by underlying malformations of the urinary tract or bladder and bowel 
emptying problems, diagnostics are of critical importance.  
It has been reported, that pediatric febrile urinary tract infections among all bacterial 
infections in small children are the most commonly missed primary diagnosis. While 
the clinical symptoms are unspecific, imaging and laboratory tests can only provide 
secondary information. The diagnosis relies on urine examination. The acquaintance 
of a meaningful, sterile urine sample requires either suprapubic puncture or 
transurethral catheterization what is commonly obviated in clinical pediatric practice, 
with most of clinicians relying on bag-urine samples. We could show that while these 
are theoretically unsuited for the purpose of diagnosing a urinary tract infection, their 
use is not an independent predictor for a lower risk for vesicoureteric reflux involved.  
Consequently also febrile urinary tract infections whose diagnosis relied on bag-urine 
samples should be taken seriously.  
Secondary diagnostics with their indication being heavily debated are warranted in 
most children after febrile urinary tract infections. Independent of the primary method 
chosen – voiding cystourethrography or dimercaptosuccinic acid scanning – ionizing 
radiation is involved. As these situations concern mainly infants and babies, any 
radiation exposure has to be considered very critically. In our second paper, we 
investigated the potential of radiation sparing measures to lower the radiation burden 
in fluoroscopic voiding cystourethrographies. We could show that judicious use of 
modern techniques can contribute to a radiation burden much lower as compared to 
the previously “best” technique, namely direct isotope cystography. This complies 
with the “as low as reasonably achievable” (ALARA) principle.  
In conclusion, our results should foster an informed but judicious use of primary and 
secondary diagnostic means after pediatric febrile urinary tract infections, aiming at 
diagnosing as many underlying malformations and at the same time lowering  
radiation exposure whenever possible. 
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The method of urine sampling is not a
valid predictor for vesicoureteral reflux
in children after febrile urinary tract
infections
Bernhard Haid, Judith Roesch, Christa Strasser, Josef Oswald
Summary
Introduction
The likelihood of detecting vesicoureteral reflux (VUR)
after febrile urinary tract infections (UTI) in children
logically should correlate with the correct diagnosis of
the UTI. Beneath the unspecific symptoms of fever
urine analysis is the main diagnostic criterion for the
exact diagnosis of febrile UTIs in children. Use of
inadequate urine sampling techniques during diag-
nosis may lead to impaired accuracy in UTI diagnosis.
This could lead to the assumption that children, having
diagnosed their UTI by the use of possibly inadequate
urine sampling techniques should not be evaluated as
consequently compared to those, where the diagnosis
relied on sterile urine sampling techniques. We hy-
pothesized that children with possibly contaminated
urine samples during the initial diagnosis may show a
lower rate of VUR in subsequent VCUGs because of a
wrong diagnosis initially compared to children, where
accurate urine sampling techniques were used.
Patients
Between 2009 and 2014, a total of 555 patients un-
derwent a primary VCUG at our department indicated
because of febrile UTIs. Patients with urine collection
methods other than bag urine and catheter/supra-
pubic aspiration (SPA) were excluded from this study
(mid-stream urine, potty urine, n Z 149). We
evaluated 402 patients (male/female 131/271, mean
age 1.91 years), VUR rates and grades were compared
between patients where urine was sampled by the use
of a urine bag only at the time of diagnosis (nZ 296,
73.6%) and those where sterile urine sampling (cath-
eter, suprapubic puncture) was performed (n Z 106,
26.3%). 4 patients were excluded due to equivocal
data on urine sampling.
Results
VUR rate in children after sterile urine sampling
using a catheter or SPA accounted to 31.1%. In those
where urine samples acquired by the use of urine
bags were used, 33.7% showed VUR on subsequent
VCUG (p Z 0.718). There were no significant dif-
ferences as to VUR grades or gender, although VUR
was much more commonly diagnosed in female pa-
tients (37.0% vs 28.2%, p Z 0.227) (Figure).
Conclusion
Children diagnosed with their UTI by use of bag urine
in our experience carried the same risk of showing a
VUR in a subsequent VCUG compared to those, where
the initial diagnosis relied e beneath clinical criteria
e on urine samples acquired by suprapubic puncture
or catheterization. Consequently urine-sampling
technique during initial UTI diagnosis alone should not
be used as predictor for the reliability of UTI diagnosis
and should not influence the further management
after UTI.
Figure (A) The probability of vesicoureteral reflux depending on the urine sampling technique
employed during the initial diagnosis of the febrile urinary tract infection prompting the voiding
cystourethrogram. (B) The probability of vesicoureteral reflux depending on the urine sampling
technique and on the patients sex.
http://dx.doi.org/10.1016/j.jpurol.2017.01.025
1477-5131/ª 2017 Journal of Pediatric Urology Company. Published by Elsevier Ltd. All rights reserved.
Journal of Pediatric Urology (2017) 13, 500.e1e500.e5
Introduction
In up to 30% of children with urinary tract anomalies, uri-
nary tract infections (UTIs) are the first clinical symptom
[1]. In these patients, early diagnosis and correct further
management including indications for further imaging may
ensure that subsequent UTIs and eventually loss of kidney
function are avoided. Whereas urinary tract anomalies
involving hydronephrosis are most often diagnosed by pre-
or postnatal ultrasound [2], the diagnosis of vesicoureteral
reflux (VUR) most often relies on the work-up performed
after UTI. Owing to the risk of renal scarring, voiding cys-
tourethrogram (VCUG) or dimercaptosuccinic acid (DMSA)
scanning is recommended after the first episode of febrile
UTI, depending on sex, age, and clinical presentation ac-
cording to the current EAU/ESPU guidelines [3]. The correct
indication for further work-up after a febrile UTI, however,
relies on a correct diagnosis of this UTI. Especially in young
children and infants, fever may be the only symptom of
UTI. UTI is diagnosed in 5.3e7% of children presenting with
fever as a main symptom [4,5].
It is widely acknowledged that the diagnosis of febrile UTIs
must rely on correct urine collection methods [3,6], partic-
ularly in patients, usually infants, where the diagnosis mainly
relies on the urine findings and culture alone with no further
specific clinical symptoms. Although widely used, bag urine
specimens have been shown to be prone to contamination
and showed a very low specificity in UTI diagnosis [7]. In an
observational study, Tosif et al. [8] found a contamination
rate of 46% for bag urine specimens. Consequently, bag urine
alone is deemed not sufficient for the diagnosis of UTIs and is
only recommended for exclusion of UTI [3]. Moreover, use of
bag urine may result in misleading antibiograms because of
contamination, and prompt a wrong antibiotic treatment
regimen. Suprapubic aspiration (SPA) and catheterization
represent the standard methods of urine collection in
younger children [3,6,8]. Clean-catch urine can be an
equivalent method for older children with acceptable cor-
relation of urine culture results [9]. Conversely, Lauet al. [10]
report that contamination rates of urine collected by cathe-
terization are as prone to contamination as bag urine samples
are, albeit only in uncircumcised boys and with fewer colony-
forming units (CFUs).
In spite of these widely acknowledged facts, many UTIs
in children are diagnosed only by bag urine and by the
absence of other specific symptoms [4]. Because referral
diagnoses for further investigation relying therewith on
possibly false-positive urine cultures, one could argue that
these children should not be investigated further until they
suffer a correctly diagnosed febrile UTI. We hypothesized
that possibly contaminated urine samples during the initial
diagnosis may result in a lower rate of VUR than those
where accurate urine sampling techniques were used. If so,
then the use of bag urine during initial diagnosis should lead
to a more restrictive indication of further work-up with
VCUG, and the urine-sampling technique could be used as a
decisive factor in VCUG indication.
Patients and methods
We retrospectively analyzed the hospital records of 555
consecutive patients (155, 28% male; 400, 72% female;
median age 22 months) who underwent primary voiding
cystourethrography (VCUG) after fUTIs and were referred
to our department between 2009 and 2014. The study
protocol was approved by the hospital’s ethics committee
(EK23/14). All patients whose urine during diagnosis of the
febrile UTI in question was collected either by catheteri-
zation, SPA, or urine bags were included into the study
(n Z 402, n Z 296 bag urine, n Z 106 catheter/SPA). Pa-
tients with other urine collection methods (mid-stream
urine, potty urine) were excluded (n Z 149). Four patients
were excluded because of equivocal data on urine sampling
(Table 1).
Table 1 Patient characteristics comparing children with bag urine samples to children with catheter/SPA urine samples.
Group 1 (n Z 296)
(children with bag urine samples)
Group 2 (n Z 106)
(children with catheter/spa urine samples)
p
Mean age (years 1.825 2.008 0.678a
Gender 104 (35.1%)m/192 (64.8)% f 27 (25.4%) male; 79 (74.5%) female 0.071b
VUR 100 (33.7%) 33 (31.1%) 0.718b
I 15 (15%) 3 (9%)
II 56 (56%) 17 (52%)
III 21 (21%) 12 (36%)
IV 7 (7%) 1 (3%)
"V 1 (1%) 0
Fever # 3 days 273 patients (92.2%) 102 pts. (96.2%)
Fever > 38.5 "C 295 patients (99.6%) 104 pts. (98.1%)
RBUS Performed in 289 patients (97.6%) Performed in 103 patients (97.1%)
Abnormalities 137 patients (47.4%) 40 patients (38.8%) 0.136b
Unilateral hydronephrosis 68 patients (49.6%) 20 patients (50%)
Bilateral hydronephrosis 28 patients (20.4%) 9 patients (22.5%)
Renal pelvis wall thickening 29 patients (21.1%) 11 patients (27.5%)
Reduced perfusion 3 patients (2.1%) 0
RBUS Z renal and bladder ultrasound; SPA Z suprapubic; VUR Z vesicoureteral reflux.
a ManneWhitney test.
b Fisher exact test.
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Febrile UTIs were diagnosed by general practitioners and
office pediatricians in pediatric outpatient departments
and at our (pediatric urologic) outpatient department.
Urine collection was performed in our outpatients depart-
ment and at the offices of practicing pediatricians, pedi-
atric urologists, and general practitioners. All of them used
commonly available urine bags, catheters, or needles
complying with medical standards. As to the patients pri-
marily seen at our department, urine was processed
immediately after it was obtained, and a dipstick analysis
by an automated dipstick analyzer was performed. Urine
cultures were done using standardized protocols in certified
microbiological laboratories. Only the combination of a
positive leucocyte esterase test and positive urine culture
in the absence of symptoms of other reasons for the present
fever was considered diagnostic for a urinary tract infection
(sterile collection method, any number of colony forming
units (CFU)/ml; bag urine and potty urine, #105 CFU/ml) [3].
Of the patients that were considered to have a febrile UTI,
almost all were severely ill (high fever # 38.5 "C in 99.2%,
fever # 3 days in 93.3%). Abnormalities in renal and bladder
ultrasound examination (RBUS, performed in 391/402 pa-
tients, 97.4%, at time of referral) were present in 47.4% of
group 1 (bag urine) versus 38.8% in group 2 (catheter/SPA,
p Z 0.136) (Table 1).
However, as this was a retrospective analysis there was
no exact standardization of methods, and for the patients
who were referred from office pediatricians we assume that
they also adhered to the basic standards mentioned above.
Patients referred with an unclear history of how the UTI in
question was diagnosed were not included into this study. A
VCUG was only indicated in those where we assumed a
correct diagnosis from all available data.
According to the EAU/ESPU guidelines [11], valid at time
of study inclusion, a primary, fluoroscopic VCUG involving
at least one representative filling and voiding cycle was
performed for every child with the diagnosis of a fUTI. After
catheterization with a 4.5 or 6F feeding tube according to
the age the bladder was filled with body warm (37 "C)
contrast agent until spontaneous micturition set in. Radio-
graphs were acquired by digital, pulsed fluoroscopy during
filling and micturition.
For every child the method of urine collection at the
time of diagnosis, the presence of VUR, and clinical and
demographic parameters were assessed and recorded.
Data were fed in to an Excel (Microsoft Corporation,
Redmond, WA, USA) sheet and statistical analyses were
performed with Prism 6.0 (Graphpad Software, San Diego,
CA, USA). After descriptive statistics, the Fisher exact test
and ManneWhitney test as well as a Kolmogorov Smirnov
analysis for the comparison of ages in the two groups and a
chi-square test for the non-parametrical data were per-
formed. A p value < 0.05 was considered significant.
Results
VUR was detected in 133 out of 402 (33.0%) patients. VUR
#III was diagnosed in 52 patients (39.1% of all children with
VUR and 12.93% of all children included into the study).
Children with bag urine collection at time of diagnosis
(group 1) were similar to children with catheter/SPA urine
collection (group 2) concerning age (p Z 0.678) and gender
(n Z 0.071) (Table 1).
In group 1, 33.7% of the children had VUR and 31.1% in
group 2 (n Z 0.718) (Fig. 1).
Of all female patients (nZ 271) 37.0% had VUR. Of those
in group 1 (192 girls), 74 patients (38.5%), of those in group
2 (79 girls) 29 patients (36.7%) had VUR (p Z 0.7691).
Of all male patients (n Z 131), 28.2% had VUR. The
probability for being diagnosed with VUR for all males in
group 1 (104 boys) came to 28.8% (30 patients) compared
with 25.9% (7 patients) in group 2 (27 patients) (pZ 0.6330)
(Fig. 2).
The difference in VUR between boys and girls (28.2% vs.
37.0%, OR 1.51, RR 1.321) was not statistically significant
(p Z 0.227).
Discussion
The urine-sampling technique at time of diagnosis of febrile
UTI taken as an isolated factor in a group of children with
clinically plausible febrile UTIs seems to be not a valid
predictor of VUR in our patients.
The rate of patients with VUR compared with in the
literature was in the lower range of what has been reported
before. In the current EAU guidelines on paediatric urology
[11] the incidence of VUR after febrile urinary tract in-
fections is denoted to be 30e50%, dependent on age. Also,
in the current AAP guidelines on urinary tract infection the
incidence of VUR is specified as 35% after the first and 74%
(n Z 10) after recurrent febrile UTIs [12]. In a meta-
analysis of nine studies [13], involving a total of 6457 pa-
tients and representing the largest series we were able to
SPA
Figure 1 The probability of vesicoureteral reflux depending
on the urine sampling technique employed during the initial
diagnosis of the febrile urinary tract infection prompting the
voiding cystourethrogram.
Figure 2 The probability of vesicoureteral reflux depending
on the urine sampling technique and on the patient’s sex.
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find, the incidence of VUR after febrile UTIs accounted to a
mean of 32% (30e37%).
Previous reports showed almost unequivocally that SPA,
transurethral catheterization, and clean-catch urine sam-
pling in toilet-trained children are more reliable for UTI
diagnosis than bag- or potty urine [3,4,6,8,9,14,15].
Although so-called clean-catch urine is considered a valid
urine collection method according to the NICE guidelines
[16], bag urine, although important for excluding a UTI if
there is a negative result, showed a high likelihood for
false-positive culture results [8]. Conversely, other reports
suggest that in a clinical environment, taking into account
many parameters, bag urine may confer a sufficient speci-
ficity for diagnostic use in pediatric UTI [17,18].
One report by Lau et al. [10] implicates that urine ob-
tained by transurethral catheterization is prone to
contamination to an extent similar to bag urine in uncir-
cumcised boys. Given that in our cohort the proportion of
boys is only 32.9%, albeit mostly (no data available) uncir-
cumcised, we would not assume that such an effect could
bias our results, even more so after the same report shows a
much lower contamination rate of urine obtained by tran-
surethral catheterization than bag urine in girls.
Using non-sterile urine sampling techniques, a significant
number of false-positive urine diagnosis has to be expected
in febrile children. In the group of examined children,
various diagnostic criteria beneath guideline conform urine
testing [3] were taken into consideration for the diagnosis
of febrile UTIs. In our population, most children who were
considered to have a UTI were severely ill (high
fever # 38.5 "C in 99.2%, fever # 3 days in 93.3%). More-
over, they lacked characteristic symptoms of possible other
causes for the fever in question. We suggest that these
additional diagnostic measures may have corrected for
possibly misleading urine tests and led to a correct diag-
nosis for referral and further imaging.
Most reports available [1,4,6], however, identified fever
and a pathologic urine culture, especially in young children
and infants, as the most important criteria of diagnosis.
The high rate of bag urine used (53%) in patients referred
to our department might be considered worrying, because
of the possible implications to culture results of a high rate
of contamination. In view of the current guidelines, rec-
ommending bag urine only as a method for exclusion but
not for the diagnosis of UTI, adherence to these recom-
mendations seems to be low in our area [3,12]. While we
can only speculate on the reasons for this low guideline
adherence, it seems probable that the convenience of a
urine bag compared with the more invasive and complex
process of transurethral catheterization of SPA is part of
the explanation. Furthermore, invasive procedures may
impose stress on children, with possible negative psycho-
logical consequences [19].
There are some limitations to this study. Because of our
retrospective design we were not able to include the clin-
ical conditions in which urine was collected, including the
number of attempts required for urine collection or if one
failed technique had preceded another. Also, urine
collection methods and the exact use of dipsticks and urine
cultures were not standardized as this is a retrospective
study. Nor are there clearly identifiable criteria for referral
to our department, which could be a source for an inclusion
bias. The strength of this dataset, however, is that it rep-
resents children that are usually referred for further work-
up after febrile UTIs and consequently those who are
relevant to our question.
Conclusion
We could show that the urine sampling technique, taken as
an isolated factor in the diagnosis of a febrile UTI in our
cohort of patients, is not a valid predictor of VUR. There-
fore we conclude, given the diagnosis of a febrile UTI was
made by an experienced clinician taking into account the
whole clinical picture by use of bag urine samples, this
should not prompt a less consequent further work-up than
the use of any formally correct (“sterile”) urine sampling
during initial diagnosis.
Conflict of interest
None.
Funding
None.
References
[1] Sastre JBL, Aparicio AR, Cotallo GDC, Colomer BF,
Hernández MC, Grupo de Hospitales Castrillo. Urinary tract
infection in the newborn: clinical and radio imaging studies.
Pediatr Nephrol 2007;22:1735e41.
[2] Nguyen HT, Benson CB, Bromley B, Campbell JB, Chow J,
Coleman B, et al. Multidisciplinary consensus on the classifi-
cation of prenatal and postnatal urinary tract dilation (UTD
classification system). J Pediatr Urol 2014;10:982e98.
[3] Stein R, Dogan HS, Hoebeke P, Ko!cvara R, Nijman RJM,
Radmayr C, et al. Urinary tract infections in children:
EAU/ESPU guidelines. Eur Urol 2014;67:546e58.
[4] Hoberman A, Chao HP, Keller DM, Hickey R, Davis HW, Ellis D.
Prevalence of urinary tract infection in febrile infants. J
Pediatr 1993;123:17e23.
[5] Shaikh N, Morone NE, Bost JE, Farrell MH. Prevalence of uri-
nary tract infection in childhood: a meta-analysis. Pediatr
Infect Dis J 2008;27:302e8.
[6] Downs SM. Technical report: urinary tract infections in febrile
infants and young children. The urinary tract subcommittee of
the American Academy of Pediatrics committee on quality
improvement. Pediatrics 1999;103:e54.
[7] Davis D. Bag urine specimens still not appropriate in diag-
nosing urinary tract infections in infants. Can J Infect Dis Med
Microbiol 2004;15:210e1.
[8] Tosif S, Baker A, Oakley E, Donath S, Babl FE. Contamination
rates of different urine collection methods for the diagnosis of
urinary tract infections in young children: an observational
cohort study. J Paediatr Child Health 2012;48:659e64.
[9] Ramage IJ, Chapman JP, Hollman AS, Elabassi M, McColl JH,
Beattie TJ. Accuracy of clean-catch urine collection in in-
fancy. J Pediatr 1999;135:765e7.
[10] Lau AY, Wong S-N, Yip K-T, Fong K-W, Li SP-S, Que T-L. A
comparative study on bacterial cultures of urine samples ob-
tained by clean-void technique versus urethral catheteriza-
tion. Acta Paediatr 2007;96:432e6.
Urine sampling technique and VUR incidence 500.e4
[11] Tekgül S, Dogan HS, Hoebeke P, Radmayr C, Kocvara R,
Nijman JM, et al. EAU guidelines on paediatric urology. Eur
Assoc Urol 2015:22e31.
[12] AAP subcommittee on urinary tract infection. Steering com-
mittee on quality improvement and management. Urinary
tract infection: clinical practice guideline for the diagnosis
and management of the initial UTI in febrile infants and
children 2 to 24 months. Pediatrics 2011;128:595e610.
[13] Jacobson SH, Hansson S, Jakobsson B. Vesico-ureteric reflux:
occurrence and long-term risks. Acta Paediatr Suppl 1999;88:
22e30.
[14] Bonadio WA. Urine culturing technique in febrile infants.
Pediatr Emerg Care 1987;3:75e8.
[15] Bauchner H, Philipp B, Dashefsky B, Klein JO. Prevalence of
bacteriuria in febrile children. Pediatr Infect Dis J 1987;6:
239e42.
[16] NICE (National Institute for Health and Care Excellence).
Urinary tract infection in under 16s: Diagnosis and manage-
ment. Clinical guideline. Retrieved from: http://www.nice.
org.uk/GC54 Clinical Guideline No. 54, 2007, checked for
updates 2013.
[17] Moral Gil L. The use of urine collection with perineal sac for
urine culture in a neonate: everything depends on the care-
fulness with which it is done. An Esp Pediatr 1997;47:85e6.
[18] Fernández JB, Echéniz JS, Raso SM, Fernández MM, De
Diego AC, Martı́n JAP. Infección urinaria en el lactante: com-
probación por punción suprapúbica del rendimiento del cul-
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Summary
Introduction
Both, fluoroscopic voiding cystourethrography
(fVCUG) and direct isotope cystography (DIC) are
diagnostic tools commonly used in pediatric urology.
Both methods can detect vesicoureteral reflux (VUR)
with a high sensitivity. Whilst the possibility to de-
pict anatomical details and important structures as
for instance the urethra in boys or the detailed
calyceal anatomy are advantages of fVCUG, a lower
radiation burden is thought to be the main advan-
tage of DIC. In the last decade, however, a rapid
technical evolution has occurred in fluoroscopy by
implementing digital grid-controlled, variable rate,
pulsed acquisition technique. As documented in
literature this led to a substantial decrease in radi-
ation burden conferred during fVCUGs.
Objective
To question the common belief that direct isotope
cystography confers less radiation burden compared
to state of the art fluoroscopic voiding cystography.
Study design
Radiation burden of direct isotope cystography in 92
children and in additional 7 children after an adap-
tion of protocol was compared to radiation burden
of fluoroscopic voiding cystourethrography in 51.
The examinations were performed according to
institutional protocols. For calculation of mean
effective radiation dose [mSv] for either method
published physical models correcting for age and sex
were used. For DIC the model published by Stabin
et al., 1998 was applied, for fVCUG two different
physical models were used (Schultz et al., 1999, Lee
et al., 2009).
Results
The radiation burden conferred by direct isotope
cystography was significantly higher as for fluoro-
scopic voiding cystourethrography. The mean
effective radiation dose for direct isotope cystog-
raphy accounted to 0.23 mSv ("0.34 m, median
0.085 mSv) compared to 0.015 mSv ("0.013, median
0.008 mSv, model by Schultz et al.) - 0.024 mSv
("0.018, median 0.018 mSv, model by Lee et al.) for
fluoroscopic voiding cystourethrography. After a
protocol adaption to correct for a longer examina-
tion time in DIC that was caused by filling until
calculated bladder capacity, mean radiation burden
accounted to .07 mSv (median 0.07 mSv) and the
values were less scattered.
Discussion
As it had to be expected from literature, radiation
dose from fVCUG, if modern image acquisition
techniques are used, is even less than from DIC. In
our protocol, according to nuclear medicine stan-
dards, bladders were filled until calculated capacity.
This resulted in a longer examination time for the
patients with a higher functional capacity, resulting
in relatively higher radiation burden. However, also
if the protocol is changed or only the patients with
relatively fast bladder emptying are considered,
radiation burden conferred by DIC is higher (at least
# 2.9, comparing the “worst” case for fVCUG with
the “best” case for DIC). Absolute radiation burden
conferred by either exam is extremely low
compared to other medical radiation exposures as
well as to environmental radiation. Consequently it
is most probably not relevant for the individual
childs future risk for cancer or other radiation
damage. However, because of repeated in-
vestigations with correspondingly higher radiation
burden in this patient group the ALARA (as low as
reasonably achievable) principle should lead to a
optimized use of fVCUG rather than an uncritical use
of DIC, given that modern acquisition standards are
available and radiation measurement is performed.
Also, fVCUG provides more information concerning
anatomical details compared to DIC.
Conclusion
Contrary to common beliefs, effective radiation
dose conferred during fluoroscopic voiding cystour-
ethrography is significantly lower than during direct
isotope cystography. The prerequisite for our find-
ings, however, is the use of modern image acquisi-
tion tools and an optimized protocol. Both exams
confer low radiation doses probably only relevant to
children undergoing repeated radiation exposure.
Nevertheless, this findings should be considered in
indication for either exam in order to reduce the
radiation burden to a minimum whilst optimizing the
information yield.
http://dx.doi.org/10.1016/j.jpurol.2014.08.015
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Introduction
Vesicoureteral reflux (VUR) is present in about 1e3% of
children in Europe and North America [1]. An understanding
of the link between VUR, urinary tract infections (UTI) and
kidney damage through recurrent pyelonephritis (APN) was
reached during the mid-to late 20th century [2]. There is,
however, still controversy on how to diagnose and to treat
children with this condition [3]. In order to diagnose VUR,
voiding cystourethrography (VCUG) is the method of
choice.
In addition to the need for catheterization or suprapubic
puncture in VCUG and the concomitant pain and discomfort
[4], another downside of VCUG is the radiation burden
involved in most examination techniques available.
The largest data resource on possible consequences of
radiation exposure is derived from information obtained
after observation of inhabitants of the surroundings of
Hiroshima and Nagasaki. A risk of cancer development of 5%
per sievert averaged over the whole population is described
in the literature [5,6]. Although the energy applied is lower
in children, the corresponding organ masses are even
smaller, accounting for a marked increase in organ- and
therefore patient-effective dose [7e9]. Consequently, a 1-
year-old infant is 10e15 times more likely to develop can-
cer after radiation exposure than an adult. In addition,
children’s organs are more radiation-sensitive and their
longer lifespan allows for late effects of radiation exposure
to become manifest [10].
The radiation doses for all available VCUG examinations
are in a very low range; however, children with VUR often
undergo repeat examinations and cumulative radiation
doses may be relevant. Therefore the ALARA (as low as
reasonable achievable) principle should be followed even
stricter for children in the indication for either radiological
investigation.
Sonographic VCUG (SVCUG) does not involve radiation
burden and can be used as an alternative to conventional or
fluoroscopic VCUG (fVCUG) [11e13] in selected indications
(screening for VUR, follow-up examinations, girls). SVCUG
is, however, highly operator dependent, technically
demanding [13] and involves off-label use of an ultrasound
contrast agent (Sonovue is not registered for children) [11].
Direct isotope cystography (DIC) has been shown to have
a comparable, if not higher sensitivity to detect VUR than
the gold-standard method of fVCUG [14e17] and, as earlier
publications showed, a lower radiation burden than con-
ventional VCUG [18e21]. The fact that detailed urethral
and bladder morphology are not as precisely visible on DIC
as on VCUG is no disadvantage in the setting of follow-up
examinations for girls and boys.
Compared to DIC, a rapid evolution of acquisition tech-
nique has occurred in VCUG. Through the use of digital,
grid-controlled variable rate-pulsed fluoroscopy, the radi-
ation exposure could be reduced to 12.5% of the previously
documented values using continuous fluoroscopy [22].
These technical advances were also reflected in the latest
adaption of the reference values for radiologic examina-
tions in children, who require comparatively low radiation
exposure only achievable by using modern techniques [23].
We therefore hypothesized that through technical ad-
vances and modern protocol design, contrary to common
beliefs, the radiation burden conferred by fVCUG could be
even lower than the radiation burden conferred by DIC. The
aim of this work was to put this hypothesis to the test by
comparing two groups of consecutive patients who under-
went DIC and fVCUG at our institution.
The problem in comparing radiation burden of the two
examinations is that the original conditions are different.
Whereas for DIC a certain amount of radiation measured in
megabequerel (MBq) is instilled into the bladder and the
patient is exposed to it for a certain time (minutes)
Figure Effective doses for DIC before and after protocol adaption and fVCUG using two different physical models for calculation
of effective doses.
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thereafter until micturition, in fVCUG a doseearea product
(DAP) (cGy cm2) reflecting the amount of radiation depos-
ited during fluoroscopy is recorded.
In order to be able to compare radiation burden, both
figures (MBq minute and cGy cm2) have to be transformed
into age- and gender-corrected effective radiation doses
(mSv) with respect to different radiation sensitivities of
different organs. For this purpose, experimental models
have been established that are used for transformation
[20,21,24].
Patients and methods
We retrospectively examined a cohort of 92 patients (85/7
female/male, mean age 2.99 years, median 2.21 years) who
underwent DIC as follow-up examination following endo-
scopic therapy of VUR. For comparison of radiation burden
we evaluated 51 (28/23 female/male, mean age 2.21 years,
median 1.0 years) consecutive fVCUGs performed primarily
for diagnosing reflux after febrile urinary tract infections
(fUTIs). For checking purposes in accordance with protocol
adaption of DIC, seven more patients (6/1 female/males,
mean age 3.25 years, median 3.0 years) that underwent DIC
were evaluated.
Direct isotope cystography
DIC was carried out by catheterization with a 6e8F urethral
catheter through which the bladder was filled by gravity
with a standardized volume ([age þ 2] # 30) of physiolog-
ical saline (0.9%) charged with an age-normalized load of
99metastabletechnetium (99mTc) as detailed previously
[25,26]. The catheter was then withdrawn. Until sponta-
neous micturition, one frame per 10 s was recorded. VUR
was graded according to nuclear medicine standards [15] as
mild, moderate or severe. A Siemens Symbia True Point
single positron emission computed tomography gamma
camera was used for acquisition. Every picture series was
evaluated by a nuclear medicine specialist and discussed in
an interdisciplinary meeting with the pediatric urologists.
After evaluation of 92 patients during this retrospective
study, this protocol was changed and the bladder was filled
until the patients needed to void, which accounted for the
shorter examination time and lead to a reduction of
dispersion of the measurement values. Subsequently, seven
patients were evaluated to study the impact of the change
in protocol.
Fluoroscopic voiding cystourethrogram
fVCUGs were performed by experienced pediatric urologists
using a Siemens Arcadis Vario C-arm digital pulsed fluoro-
scopic unit. Children were catheterized with 4e6F feeding
tubes and bladders were filled by gravity (30 cm H2O) except
when a 4F feeding tube was used, when bladders were filled
slowly with 20-mL syringes until micturition. A fluoroscopic
picture before application of contrast medium was stored
using last image holdmode. At this point, the automatic tube
tension adjustment was switched to manual and the tube
tension was adjusted to the lowest reasonable value. The
region to be examined was faded in to by iris- and lateral
shades were employed to limit the radiation exposure to the
region of interest. Then contrast medium was injected
slowly until onset of voiding. During voiding, pictures of the
bladder, urethra (in boys lateral views), and the kidney re-
gion were acquired. For picture acquisition only fluoroscopy
with ultra-short pulses and last image hold technology was
used; we did not record picture sequences or still shots. This
allowed us to record up to four pictures per second of fluo-
roscopy time, which again is the explanation for the short
fluoroscopy time during fVCUG in our patients. The feeding
tube was only removed in rare cases when voiding was not
possible. In 30 out of 51 fVCUGs, cyclic filling (2e4 times) was
performed. After the examination, the feeding tube was
removed and another plain picture was acquired. Boys
received one dose of antibiotic to prevent iatrogenic UTI.
Data acquisition and statistical analyses
Patient data were acquired retrospectively using the
documentation in the local hospital information system
(SAP) and radiation dose measurement data as well as
exposure time were acquired using the dedicated docu-
mentation systems. Data were fed into a Microsoft Excel
spreadsheet and statistical analyses were carried out using
the same software. For comparison of mean values
(effective radiation doses) the t-test for normally distrib-
uted groups was used.
Calculation of equivalent doses
In order to compare the radiation burden of DIC versus
fVCUG, effective radiation doses were calculated for both
examinations based on published models. For DIC the model
published by Stabin and Gelfand [21] was used; the equiva-
lent dose (ed)/min/MBq was deducted and then the relative
ed for each patient was calculated. For fVCUG two different
models published by Schultz et al. [20] and Lee et al. [24]
were employed: starting from DAP values a sex- and age-
adjusted ed was calculated for each patient using the co-
efficients provided in the above mentioned publications.
The accurateness of these calculations is estimated to
"10e15% by the authors [20,21,24]. Radiation dose calcu-
lations were approved by two local hospital radiation
physicists (EP, BG).
Results
Direct isotope cystography
For all patients who underwent DIC, mean exposure time
(Z time spent with tracer insider the bladder) was 37.8 min
(median 13.5 min, range 3.17e286.83 min). The mean dose
of 99mTc applied was 32.79 MBq (median 31 MBq, range
13e85 MBq). This results in a mean effective radiation dose
of 0.23 mSv ("0.34 mSv, median 0.085 mSv). If only the
patients with an exposure time under 15 min (n Z 52) are
evaluated, the mean effective radiation dose is 0.062 mSv
("0.034 mSv, median 0.064 mSv) (Table 1).
After changing the DIC protocol by filling until micturition
instead of filling until the calculated bladder capacity,
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another seven patients were evaluated. Mean exposure time
was reduced to 11.07 min (median 9.67, range 7.5e23.6).
The mean dose of 99mTc applied was 33.43 MBq (median
32 MBq, range 26e49 MBq). This results in a mean effective
radiation dose of 0.07 mSv (median 0.07 mSv) (Table 1).
Fluoroscopic voiding cystourethrography
For the fVCUG group, the mean fluoroscopy time was 7 s
(median 4 s) and mean dose DAP was 3.3 cGy cm2 ac-
counting for a mean effective radiation dose of 0.024 mSv
("0.018, median 0.018 mSV) as calculated using the model
of Schultz et al. [20] and 0.015 mSv ("0.013, median
0.008 mSV) as calculated using the model of Lee et al. [24]
(Table 1).
Comparison
Comparison of the mean effective radiation doses of DIC
and fVCUG (Table 1) reveals a highly significant
(p Z 0.00005 Schultz, p Z 0.00002 Lee) difference in
effective radiation dose of 0.206 mSv (mean). After the
protocol change and with only seven patients, a statistical
comparison with calculation of p-values was not valid (small
group size); there was, however, as expected, a more lev-
eled examination time and a lower radiation dose than the
former protocol and a higher dose than in fVCUG (Fig. 1A).
Discussion
Examinations used in uropediatric diagnostics involve,
relative to other disciplines (abdominal CTs, barium swal-
lows, irrigoscopies) [10], relatively low radiation doses.
Nevertheless, reducing the radiation burden to children is
critical, either through avoiding unnecessary investigations,
through implementation of radiation-saving protocols, and
through implementation of technological advances.
It is commonly assumed that DIC confers a lower radia-
tion burden than VCUG. According to our findings, radiation
burden seems to be critically dependent on protocols used
for either examination and this belief seems to be partly
based on historical data.
In the literature [19,21,25] radiation burden during DIC
is calculated by different models that take into account the
exposure time towards the instilled radionuclide and the
instilled activity. The mean effective radiation dose ac-
cording to these publications accounts to 0.047e0.053 mSv
[21], being considerably lower than the published mean
effective radiation dose for conventional VCUG examina-
tions (0.4e2.2 mSv) [20]. The wide range for radiation
burden during radiologic VCUG examinations is explained by
different acquisition techniques.
The use of modern acquisition technique, as for example
pulsed fluoroscopy, leads to an impressive reduction of
radiation exposure by up to factor 8 [22]. Better image
quality and last image hold technology makes the acquisi-
tion of still shots widely unnecessary. A current publication
by Born et al. [23], dealing with the lowered German
diagnostic reference doses reports on mean DAPs for 413
examinations, was 0.97 dGy cm2 (0.1e11.1 dGy cm2)
translating into 0.021 mSv using the conversion model we
used for our data. This corresponds very well with our
experience and our mean effective radiation dose
(0.024 mSv) using a comparable acquisition technique and
proves that our fVCUG radiation measurements reflect the
current state of the art in this field.
The vast range of time with the tracer inside the bladder
(mean 37.8 min, median 13.5 min, range 3.17e286.83 min)
and consequently effective radiation doses during DIC in our
patientswas caused by filling according to calculated bladder
capacity ([age þ 2] # 30). This protocol is detailed in the
“Procedure guideline for radionuclide cystography in chil-
dren” published by the Society of Nuclear Medicine in 1997
[25]. Children with reflux tend to have big bladder capacities
as documented in the literature [27]. In consequence, their
bladders are not adequately filledwith the calculated volume
andexamination time is delayed. Also, the instilled activity in
our patients was considerably higher (mean 32.79 MBq, me-
dian 31 MBq) than documented in the literature (11e22 MBq
for the same age group) [21]. A re-evaluation after adapting
the DIC protocol (instillation until the patient needs to void
instead of calculated bladder capacity) led to a significant
reduction in mean radiation dose, as expected by reduction
of the diversion of the time measurement values, however,
the median changed only slightly (0.085 mSv before
compared to 0.07 mSv after protocol adaption).
For fVCUG our exposure times (mean 7 s, median 4 s)
were much lower than the mean exposure time docu-
mented in the literature (mean 34 s) [23] because of
acquisition of only last image hold fluoroscopy pictures (up
to 4 pictures/second of fluoroscopy). Together with
consequent in-fading, reduction of tube tension and use of
pulsed, digital fluoroscopy with last image hold mode this
results (mean 3.3 cGy cm2, median 2.17 cGy cm2, range
0.46e30.3 cGy cm2) in lower DAPs than much of those
documented in previous literature (83e534 cGy cm2) [20].
Table 1 Data on radiation burden of either method.
Effective radiation doses (mSv) are printed in bold letters.
DIC n Z 92 Mean Median Range
Time (min) 37.8 13.5 3.17e286.83
Applied dose (MBq) 32.79 31 13e85
Effective dose (mSv) 0.23 0.085 0.02e2.18
Effective dose (mSV) in
patients with time
(min) $ 15 (nZ 52)
0.062 0.064 0.02e0.24
fVCUG n Z 51 Mean Median Range
Time (s) 7.2 4.0 2.0e24.0
Dose area product
(cGy cm2)
3.3 2.17 0.46e30.3
Effective dose (Schultz
et al. 1998) (mSv)
0.024 0.018 0.0055e0.08
Effective dose (Lee
et al. 2009) (mSv)
0.015 0.008 0.01e0.185
DIC after protocol
adaption n Z 7
Mean Median Range
Time (min) 11.07 9.67 7.5e23.6
Applied dose (MBq) 33.43 32 26e49
Effective dose (mSv) 0.07 0.07 0.04e0.15
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The age difference between the fVCUG group and DIC
group of patients is caused by the fact that indication for
fVCUG where 52 consecutive patients were recorded
include mainly reflux detection and control (usually before
of around age 1) and DIC was used for follow-up after ET of
VUR, which usually occurs later. The age difference and the
consecutive difference of DAP was taken into account by
adjusting factors for conversion of cGy cm2 to mSv as pro-
posed by Schultz et al. [20] and Lee et al. [24].
Compared to other diagnostic procedures with earth and
cosmic radiation, DIC and fVCUG confer a relatively low
radiation burden. Therefore, both examinations, taken as
isolated radiation burden, are most probably not relevant to
the individual child’s future risk for cancer or other harm
connected with the exposure to ionizing radiation. However,
the relatively higher radiation sensitivity of children, a 1-
year-old infant is 10e15 times more likely to develop cancer
after radiation exposure than an adult [10], has to be taken
into account. Additionally, VURpatients are likely to undergo
repeated VCUG examinations and other diagnostic pro-
cedures involving radiation exposure (e.g., DMSA scans) ac-
counting for an accumulation of radiation dose (Fig. 1B).
Figure 1 (A) Effective doses for direct isotope cystography (DIC) before and after protocol adaption and fluoroscopic voiding
cystourethrography (fVCUG) using two different physical models for calculation of effective doses. (B) Effective doses in direct
isotope cystography before and after protocol adaption as well fVCUG compared to the literature and other examinations relevant
in pediatric urology.
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A possible limitation of our study is the calculation of
equivalent dose using model systems. These models, how-
ever, are the best and probably only instrument available to
render comparable biologically relevant radiation burden
caused by different examinations. Bearing in mind the
importance of avoiding radiation to patients and especially
to children, it is considered important to rely on these
model systems in order to optimize protocols and protect
our patients from potentially harmful radiation exposure.
Conclusion
Contrary to common beliefs, effective radiation dose
conferred during fVCUG, if modern image acquisition tools
and an optimized protocol are applied, is significantly lower
than during DIC. Although both examinations confer low
radiation doses probably only relevant to children under-
going repeated radiation exposure, this finding should be
considered in indication for either examination in order to
reduce the radiation burden to a minimum whilst opti-
mizing the information yield.
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[16] Sükan A, Bayazit AK, Kibar M, Noyan A, Soyupak S, Yapar Z,
et al. Comparison of direct radionuclide cystography and
voiding direct cystography in the detection of vesicoureteral
reflux. Ann Nucl Med 2003;17:549.
[17] Dikshit MP, Acharya VN, Shikare S, Merchant S, Pardanani DS.
Comparison of direct radionuclide cystography with mictu-
rating cystourethrography for the diagnosis of vesicoureteric
reflux, and its correlation with cystoscopic appearances of the
ureteric orifices. Nephrol Dial Transpl 1993;8:600.
[18] Darge K. Voiding urosonography with US contrast agents for
the diagnosis of vesicoureteric reflux in children. II. Compar-
ison with radiological examinations. Pediatr Radiol 2008;38:
40.
[19] Conway JJ, Belman AB, King LR, Filmer RB. Direct and indirect
radionuclide cystography. J Urol 1975;113:689.
[20] Schultz FW, Geleijns J, Holscher HC, Weststrate J,
Zonderland HM, Zoetelief J. Radiation burden to paediatric
patients due to micturating cystourethrography examinations
in a Dutch children’s hospital. Br J Radiol 1999;72:763.
[21] Stabin MG, Gelfand MJ. Dosimetry of pediatric nuclear medi-
cine procedures. Q J Nucl Med 1998;42:93.
[22] Ward VL, Strauss KJ, Barnewolt CE, Zurakowski D,
Venkatakrishnan V, Fahey FH, et al. Pediatric radiation
exposure and effective dose reduction during voiding cys-
tourethrography. Radiology 2008;249:1002.
[23] Born M, Spiller L, Bachour H, Heydweiller A, Franke I. Dose
area product of pediatric VCUG with regard to the strongly
lowered German diagnostic reference levels. Rofo 2013;185:
262.
[24] Lee R, Thomas KE, Connolly BL, Falkiner M, Gordon CL.
Effective dose estimation for pediatric voiding cystour-
ethrography using an anthropomorphic phantom set and metal
oxide semiconductor field-effect transistor (MOSFET) tech-
nology. Pediatr Radiol 2009;39:608.
[25] Mandell GA, Eggli DF, Gilday DL, Heyman S, Leonard JC,
Miller JH, et al. Procedure guideline for radionuclide cystog-
raphy in children. Society of nuclear medicine. J Nucl Med
1997;38:1650.
[26] Agrawal V, Rangarajan V, Kamath T, Borwankar SS. Ves-
icoureteric reflux: evaluation by bladder volume graded direct
radionuclide cystogram. J Indian Assoc Pediatr Surg 2009;14:
15.
[27] Sillén U, Brandström P, Jodal U, Holmdahl G, Sandin A,
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